This article was published in March of 2023 and reviews the most up-to-date progress in pyridoxine-dependent epilepsy (PDE-ALDH7A1). This section focuses on treatment options.

This article was published in March of 2023 and reviews the most up-to-date progress in pyridoxine-dependent epilepsy (PDE-ALDH7A1). This section talks about biomarkers and newborn screening.

This article was published in March of 2023 and reviews the most up-to-date progress in pyridoxine-dependent epilepsy (PDE-ALDH7A1). This section covers a summary of biochemistry and genetics.

This article was published in March of 2023 and reviews the most up-to-date progress in pyridoxine-dependent epilepsy (PDE-ALDH7A1). This section covers the clinical aspects of PDE.

This article was published in March of 2023 and reviews the most up-to-date progress in pyridoxine-dependent epilepsy (PDE-ALDH7A1). This section is on the three types of PDE.

This is an introduction to an article that was published in March of 2023 and reviews the most up-to-date progress in pyridoxine-dependent epilepsy (PDE-ALDH7A1).

If you’re a parent or caregiver of a child with Pyridoxine-Dependent Epilepsy (PDE), you know how crucial early diagnosis and treatment are.

In this post, we will delve into the genetic underpinnings of PDE, shedding light on the diverse types of mutations associated with PDE.